NSAID use is associated with an increased risk of death from RCC among women but not among men, researchers found.

The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...

The story of Joao Macaroco, a Fall River father with end-stage kidney failure who urgently needs an O Positive donor to save ...

Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study. By creating the most complete and detailed genetic 'map' of kidney function to ...

Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Background: Chronic kidney disease (CKD) is a global public health issue. In recent years, the effectiveness of finerenone for treatment of CKD has been the subject of considerable debate. The main ...

Enoxaparin [23] Observe patients with moderate ... In hemodialysis patients or in patients with acute renal failure (CL cr of <15 mL/min or SCr of >6.0 mg/dL), lepirudin should be avoided or ...

Objective To systematically identify and describe self-management interventions for adult patients with chronic kidney disease (CKD). Setting Community-based. Participants Adults with CKD stages 1–5 ...

Use of proton pump inhibitors appears to increase the risk for kidney failure among patients with CKD. Use of proton pump inhibitors (PPIs) may spur progression to kidney failure in patients with ...

A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced the risk of kidney disease worsening by 24% in people who also had diabetes. It also reduced the ...

By Dani Blum The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.